Skip to content
Fencer Intel
medium 5.3

CVE-2026-86432 json

commonmark 2.0.0 before 2.8.4 Denial of Service via XML

published 2mo ago modified last mo. also EUVD-2026-72390

cvss
5.3
version 3.1, CNA
cisa kev
Not listed
not in CISA's catalog
epss
0.4%
EPSS 0.4% chance of exploitation in 30 days, percentile 36%
public exploits
0
none known

Summary

commonmark versions from 2.0.0 before 2.8.4 contain a denial of service vulnerability in XmlRenderer that emits depth-proportional indentation for every XML tag. Attackers can provide deeply nested Markdown or AST structures to cause quadratic memory consumption and output amplification, exhausting server resources.

Patch / fix

  • thephpleague commonmark 2.8.4
  • php-league-commonmark Debian 14 2.9.0-1

debian advisories DEBIAN-CVE-2026-86432

Is CVE-2026-86432 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.

Check with Fencer

CISA SSVC

Exploitation
none
Automatable
yes
Technical impact
partial
Assessed
2mo ago

Exploit prediction

0.42% chance of exploitation in the next 30 days, higher than 36% of all scored CVEs (FIRST EPSS, 2026-11-11).

CVSS scores

assigned by version score vector
CNA 4.0 6.9 CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N
CNA 3.1 5.3 CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L
CNA 4.0 6.9 CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Affected products

  • thephpleague commonmark

Classification

Weakness
  • CWE-405 Asymmetric Resource Consumption (Amplification)

References

Sources

Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.

CPEs and fixed versions use Anchore's correction of NVD's data: Added CPE configurations because not yet analyzed by NVD.